Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 17Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 6Neoplasms 4Neoplasm Metastasis 4Skin Neoplasms 3Lung Neoplasms 3Gastrointestinal Neoplasms 3Rectal Neoplasms 2Digestive System Neoplasms 2Colonic Neoplasms 2Solid Tumors Harboring a BRAF V600 Mutation 1Solid Tumors 1Skin Diseases 1Rectal Diseases 1Pancreatic Neoplasms 1Neurofibromatosis 1 1Intestinal Neoplasms 1Intestinal Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1Gastrointestinal Diseases 1Digestive System Diseases 1Colonic Diseases 1Brain Neoplasms 1

Interventions

Irinotecan 3Bevacizumab 3Leucovorin 2Fluorouracil 2napabucasin 1encorafenib 1Pemetrexed 1Oxaliplatin 1Ocoxin 1Levoleucovorin 1Leukocyte Immunoglobulin-like Receptor B1 1KRN-330 1Drug Therapy 1Cetuximab 1Capecitabine 15,10-methylenetetrahydrofolic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Rectal Diseases × encorafenib × Clear all
NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Pfizer

Phase 3 Active not recruiting
831 enrolled 2 FDA
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡